NCT06011291View on ClinicalTrials.gov

A Study of SYH2051 Monotherapy in Advanced Solid Tumors or in Combination With Radiotherapy in Locally Advanced Head and Neck Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

August 15, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

August 31, 2025

Conditions
Solid TumorsHead and Neck Cancer
Interventions
DRUG

SYH2051 tablets

Arm A: Five dose levels will be administered sequentially. Arm B and C: Concurrently administered with RT, and 2 weeks adjuvant treatment after RT.

RADIATION

Intensity-Modulated Radiation Therapy (IMRT)

Radical or adjuvant radiotherapy

Trial Locations (1)

050000

RECRUITING

Clinical Trials Information Group, Shijiazhuang

All Listed Sponsors
lead

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

INDUSTRY